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Nephroptosis and hypertension. D. de Zeeuw, A. I. M. Donker, J.
Burema, G. K. van der Hem, and E. Mande,na. Department of
Medicine, State University of Groningen, Groningen, the Nether-
lands. An abnormal renal mobility in the upright position (neph-
roptosis) is observed in 20% of women, predominantly on the right
side. Fibromuscular dysplasia (FMD) of the renal artery is also
observed mainly in women on the right side. The sex-dependency
and the equal incidence with which the right kidney is affected by
both phenomena suggest an association between FMD and neph-
roptosis. Moreover, a relation is suspected between renal mobility
and kidney perfusion. In order to evaluate nephroptosis in its
relation to FMD and/or hypertension, the renal mobility was
studied in 14 patients with a FMD of the renal artery, in 102
patients with essential hypertension, and in 89 patients with a
normal blood pressure, by comparing the patients' recumbent and
upright positions on film made during i.v. pyelography. The degree
of mobility (m) was expressed in millimeters. It was found that, in
contrast to males, females often showed a marked renal mobility
and that the renal mobility correlated with the blood pressure (r =
0.50, N = 105, P < 0.001). Female patients with hypertension
(diastolic pressure  100 mm Hg) showed a distinct renal mobility
on the right side (N = 63, m = 6.29 cm, SD = 1.99 cm). Normoten-
sive females had a significantly lower (P < 0.001) mean right renal
mobility (N = 42, m = 3.42 cm, SD = 2.12cm), The difference was
not significant on the left side (P > 0.10). The blood pressure-renal
mobility relation was confirmed by a multivariate regression analy-
sis. Moreover, the difference in right kidney mobility remained
significant (P < 0.001) after matching the hypertensives and con-
trols with respect to age, body weight, body height, parity, and
medication. Fibromuscular dysplasia of the renal artery was ac-
companied by an impressive renal mobility on the side involved
(8.6 1.7 cm on the right side and 6.8 2.8 cm on the left side).
The results of this study indicate that in women nephroptosis
contributes, directly and/or indirectly, to the development of high
blood pressure.
Antiproteinuric effect of indomethacin in rats with experimental
extramembranous (Heymann-type) nephritis. F. W. J. Gribnau,
H. L. M. Siero, G. J. Fleuren, Ph. J. Hoedemaeker, and P. G. A. B.
Wzjdeveld. Pharmacological Institute, and Division of Nephrology of
Department of Medicine. University Nijmegen, and Department of
Pathology. University Groningen, The Netherlands. Indomethacin is
known to have an immediate and reversible antiproteinuric effect
in the human nephrotic syndrome. The purpose of this work was to
study whether this effect could likewise be realized in an animal
experimental model. In inbred male PVG/C rats, extra-
membranous glomerulopathy was induced by repeated i.p. immu-
nization with a diazotized Wistar rat kidney antigen. The experi-
mental disease is associated with proteinuria (400 to 900
mg/rat/day) and hypalbuminemia (about 26% of healthy con-
trols). There is no impairment of GFR; natriuresis is normal and
no edema occurs. Indomethacin given at different times in the
course of the disease (daily doses of 2 X 0.15 to 2 X 0.60 mg/rat)
failed to reduce protein excretion in animals receiving standard
feed (sodium content, l9lEq/g of feed). When animals on a salt-
restricted diet (5zEq/g) were given the drug (2 X 0.60 mg daily), an
immediate decrease of proteinuria to about 60% of control values
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was observed. The effect was reversible after discontinuation of
treatment. In concentrations existing in plasma at the dose given in
these experiments, indomethacin inhibits the synthesis of prosta-
glandins. Therefore, theoretically, indomethacin effects are likely
to occur, especially in situations with increased prostaglandin syn-
thesis and/or enhanced activity of substances counteracting pros-
taglandins' effects, e.g., angiotensin. From these considerations,
one might speculate that only superimposing salt restriction on the
hypalbuminemia in these animals produces sufficiently high angio-
tensin activity, probably connected with sufficiently high prosta-
glandin synthesis rate, needed to give therapeutic effects of in-
domethacin on kidney function.
Effects of indomethacin on the course of extramembranous (Hey-
mann-type) glomerulonephritis in rats. F. W. J. Gribnau, H. L. M.
Siero, G. J. Fleuren. Ph. J. Hoedemaeker, and P. G. A. B. Wjjdeveld.
Pharmacological Institute, and Division of Nephrology of the De-
partment of Medicine, University Nijmegen, and Department of
Pathology, University Groningen. The Netherlands. Opinions differ
as to whether indomethacin favourably influences the course of
human chronic glomerulonephritis. Therefore, we have studied the
effect of indomethacin on the natural course of an experimental
glomerulonephritis in rats. Inbred male PVG/C rats were immu-
nized (12 injections i.p. in six weeks) with a diazotized Wistar rat
kidney antigen and divided into indomethacin-treated and control
groups. For periods up to 500 days, proteinuria, endogenous
creatinine clearance (ECC), and renal morphology (light micros-
copy, immunohistochemistry, and electron microscopy) were
studied. The disease was found to be associated with proteinuria (400
to 900mg/rat/day), hypalbuminemia (about 26% of controls) and
hypercholesteremia (10 mmoles/liter). ECC remained normal, as
did renal capacities for sodium excretion and retention. In animals
kept on standard feed (l9lEq of Na/g of feed), no edema oc-
curred. From week four on, a nonproliferative glomerulonephritis
started, with characteristic "spikes," granular pattern of immuno-
fluorescence (IgG and C3), subepithelial electron-dense deposits
which increased in size and irregularity, and thickening of the
glomerular basement membrane (GBM). From week 33 on, depos-
its gave place to electron-microscopically empty "holes" in the
GBM. About week 75, these holes had been filled with GBM
substance. Only if the drug was given during the phase of immuni-
zation, indomethacin dose-dependently reduced the proteinuria by
26% (dose, 0.30 mg/rat/day) to 45% (dose, 0.60 mg/rat/day). ECC
was not influenced. Change of the morphologic features was only
seen in electron microscopy, and the differences seemed to be of
minor importance. In indomethacin-treated animals, sub-
endothelial electron-dense deposits were observed, likewise seen in
nonimmunized indomethacin-treated controls. Indomethacin
seemed to accelerate the electron microscopic characteristics of the
disease in the first 22 weeks, and later on in the disease, to reduce
the number of optically empty spaces in the GBM. Although
findings in one experimental nephritis in one animal species are
admissible as evidence, the reported results lend no support to the
view that long-term indomethacin treatment might be beneficial in
chronic glomerulonephritis. Possibly, situations analogous to the
phase of immunization in these experiments, in this respect, are
exceptions.
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Effect of immediate aortic constriction on sodium excretion during
acute extracellular volume expansion in the dog. N. Lameire, M. A.
Walterloos, I. Becaus, S. Ringoir. Nephrological Division, Univer-
sity Hospital, De Pintelaan, Ghent. Belgium. Studies in the rat have
indicated that aortic constriction (AC) prior to expansion of the
extracellular volume (ECV) prevents the natriuretic response nor-
mally seen in this setting. These findings are taken as evidence
against the role for an extrarenal natriuretic hormone. In order to
evaluate this finding in the dog, clearance studies were performed
to compare the effect of AC prior to and after ECV expansion of
7.5% body wt with 0.9% saline. Two groups were studied: Group 1.
Delayed clamp studies (N = 7). After hydropenic clearances, saline
was given for 40 mm, and the renal perfusion pressure (RPP) was
reduced to a mean of 80 mm Hg while the saline was continued.
Group 2. Immediate clamp studies (N = 8). After hydropenic clear-
ances, RPP was decreased to 75 mm Hg followed by saline-
loading. In both groups, clearance collections were obtained
60 mm after the initiation of the saline-looking. In group I,
total kidney glomerular filtration rate (GFR) and para-amino-
hippurate clearance remained constant (21.7 vs. 18.8 and 60 vs. 54
mi/mm/kidney; P> 0.05). Absolute and fractional sodium excre-
tion increased from 29.6 to 63.0jEq/min (P < 0.05) and from 1.08
to 2.58%, respectively (P < 0.02). In group 2, total kidney GFR
decreased from 81 to 49 mI/mm/kidney (F < 0.01). Both absolute
and fractional sodium excretion, however, increased from 30. I to
57.1Eq/min (P < 0.05) and from 0.80 to 1.85% (P < 0.02),
respectively. The arterial hematocrit dropped from 43 to 25% (P <
0.01) and from 40 to 26% (P < 0.01) in groups I and 2, respec-
tively. After release of the AC, fractional sodium excretion in-
creased to 10.5% (P < 0.001) in both groups. These results indicate
that immediate AC does not obviate the natriuretic response to
saline-loading in the dog and, therefore, does not permit us to
exclude an extrarenal "natriuretic hormone" factor as mediator of
the increased natriuresis after acute ECV expansion.
Studies about the pathogenesis of the hemolytic-uremic syndrome
(HUS). L. Monnens, I. Lambooy. P. van Wieringen, J. Bakkeren.
Si. Radboud Ziekenhuis, Kindernefrologie, Nijmegen. The patho-
genesis of HUS remains still partly obscure. In two different ways
we have tried to elucidate its pathogenesis. First, endotoxin was
sought in the peripheral circulation of children with HUS, and
second, we have tried to measure circulating endothelial cells in
children and also in the experimental animal. Endotoxin has all the
qualities of being the prime mediator of acute intrinsic renal fail-
ure. In HUS, endotoxinemia may arise from the flora of the
damaged bowel. The limulus assay is generally accepted as being
highly specific for gram-negative endotoxins, as well as being the
most sensitive test at present. In eighteen children with HUS, we
were unable to detect circulating endotoxin by using the limulus
lysate assay. Ten children with proven gram-negative septicemia
yielded positive limulus assays. All normal control children
showed negative limulus assays. Some evidence is available in
favor of the primary character of the damage to the endothelium of
the arterioles and capillaries in HUS. In four children with 1-IUS,
tested immediately after admission, circulating endothelial cells
could not be demonstrated. To evaluate these results, we induced
the generalized Shwartzman reaction by liquoid in the rat. Liquoid
has a direct injurious effect on endothelium. We demonstrated that
the number of circulating endothelial cells in this experimental
model depended not only on the dose of injected liquoid, but also
on the time passed after injection. A huge number of circulating
endothelial cells was seen one hour after the injection of liquoid.
Twenty-four hours after the injection, circulating endothelial cells
were no longer detected. If in the child with HUS, the number of
circulating endothelial cells was comparable with the number of
these cells in the rat four hours after liquoid injection, the endo-
thelial cells would have been detected. The negative findings in
children with HUS can be explained by the fact that either endo-
thelial lesions are not extensive or, and this is probably the best
explanation, that these cells have already disappeared.
Serum protein-binding of phenylbutazone during the course of
acute renal failure. M. Mussche, F. Belpaire, M. Bogaert. S. Ring-
oir. Department of Internal Medicine, Nephrological Division, and
Heymans Institute of Pharmacology, University Hospital, De Pinte-
laan, Gheni, Belgium. Decreased drug serum protein (SPB) has
been described in patients with chronic renal failure. Scanty infor-
mation exists about the evolution of SPB during the course of
human acute reversible renal failure, SPB of '4C-phenylbutazone
was studied in five patients with acute renal failure: in four of them,
hemodialysis was temporarily required. For determination of SPB,
an equilibrium dialysis method was used. During the oliguric pe-
riod, a very low SPB (mean of 84%) was observed. During recovery
from acute renal failure, SPB progressively normalized in all to
> 94%. This problem was further investigated in an animal model
of acute toxic renal failure. The latter was induced in rabbits by i.v,
administration of uranyl nitrate (UN) in a dose of 2 mg/kg. SPB of
phenylbutazone decreased in parallel with deterioration of renal
function, as estimated by a blood urea level (from control value of
95% to 80—85% for SPB and from a control value of 0.3 g/liter to 3-
5 g/liter for blood urea). Normalization of SPB was observed in
two rabbits with recovery of their renal failure, while the others
died in renal failure. The decreased SPB in uremic rabbits could
be explained by a significant decrease in binding constant (K),
since a normal number of binding sites (N) as compared to con-
trols was observed (5 control rabbits: K (M >< l0) = 49.14
5.22, N = 1.66 0.11; uremic rabbits: K = 19,62 3.26, N
1.41 + 0.07). Conclusion.' I) The decreased drug serum protein-
binding, observed in both human and animal models of acute
renal failure, is reversible with recovery of the renal function. 2)
These findings may be important in the therapeutic drug man-
agement of patients with acute renal failure.
"Upright hyperkalemia": A manifestation of hyporeninism in
young patients with glomerulonephritis (GN). J. P. Rado, T. A.
Simatupang, P. Hoer, and E. J. Dorhout Mees. Department of
Nephrology and Hypertension, University Hospital, Utrecht, The
Netherlands. Hyperkalemia is the most conspicuous abnormality in
selective hypoaldosteronism, which may be due to defective
biosynthesis of aldosterone, or insufficient release of renin, or a
combination of both. Selective hypoaldosteronism due to hypo-
reninism has been reported mostly in older people. We report two
young patients (the first, aged 29 yr, with mesangial proliferative
"immunocomplex" GN; the second, aged 18 yr, with Alport's
disease) with stable chronic renal failure and hyperkalemia not
proportional to the moderate degree of renal insufficiency (creati-
nine clearances varied between 15 to 25 mI/mm). Hyperkalemia
(serum potassium [Sn] range, 5 to 7.3 nmoles/liter) was observed
in both subjects in the outpatient situation during a normal so-
dium, low potassium diet, with or without Resonium treatment.
Repeatedly, after admission to the hospital, high S fell to the
approximately normal level (P < 0.01), even during a normal
dietary potassium intake (80 mmoles/day), irrespective of the
dietary sodium content. In the hospital, the patients were not
confined to bed, but had the restricted activity of a normal hospital
life. Blood sampling was done early in the morning in the recum-
bent position or shortly after awakening. Adrenal function was
normal as evaluated by adrenocorticotropic hormone (ACTH)
stimulation (there was a normal increase in plasma cortisol and
plasma aldosterone levels). Intrinsic tubular potassium excreting
capacity was not defective, as in both patients potassium excretion
could exceed filtered potassium. Hyporeninism was diagnosed on
the basis of unresponsiveness of plasma renin activity (PRA) to the
upright posture. PRA (during sodium [Na] restriction) was 74.2 ng
of angiotensine I (Al) (100 mI/hr in the first patient, and 155 ng of
AI/l00 mi/hr in the second one) (normal, 280 ng of AI/l00
mi/hr. Urinary aldosterone excretion during normal Na intake
was 0.9 mEq/24 hr in the first and 13.4 mEq/24 hr in the second
patient, increasing only slightly to 4 mEq/24 hr and 23.2 mEq/24
hr, respectively, during a 50 mmole Na diet, (Normal: <20 mEq on
normal Na intake, and > 25 mEq on low Na intake.) Further
abnormalitis, in addition to hyporeninism, in both patients were:
1) a disturbed cellular uptake of potassium, and 2) an altered
tubular response to a pharmacologic dose of aldosterone. Details of
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these will be presented elsewhere. During dietary Na restriction,
both patients proved to be capable of excreting a normal potas-
sium load, while maintaining normal SR levels. After discharge
from the hospital on the same Na restricted diet, SR levels increased
again slightly, but remained definitely lower than during the pre-
admission outpatient period (P K 0.01). Increase in Na intake was
again followed by an increase in SR levels. In our young, hyporeni-
nemic, hypoaldesteronemic patients with GN, hyperkalemia was
significantly (P < 0.01) more pronounced in the outpatient Situa-
tion (especially during unrestricted Na intake) in which the pa-
tients had to deal with the activities of normal daily life mostly in
the upright position, as contrasted to the restricted activity and
recumbency in hospital life. We believe that insuffi dent physiologic
adjustments in response to the upright position are instrumental in
causing 'upright hyperkalemia." The "spontaneous" fall in SR
levels after admission of these patients to the hospital may be
deceptive and lead to underestimation or neglection of the prob-
lem.
Effects of indomethacin on glomerular permeability. R. G. W. L.
Tiggeler and P. G. A. B. Wijdeveld. Division of Nephrology, Depart-
ment of Internal Medicine. Sint Radboud Ziekenhuis, Nijmegen, The
Netherlands. Indomethacin reduces proteinuria in glomerular leak-
age. There is no good explanation for this effect. We studied
whether it could be explained by an influence on glomerular per-
meability. Parameters were the fractional clearance of '25J-labelled
polyvinylpyrollidone (Cp) and the clearance quotient for lgG
and albumin (selectivity index, SI). was studied in 24, SI in
33 patients with a nephrotic syndrome. Measurements were per-
formed in the untreated condition, and on day five of treatment,
with indomethacin (150 mg orally, divided over three doses). The
C1. in untreated condition showed the three types described
previously: CPVP as in normals (3 patients); normal for mole-
cules K 40 A and increased for molecules > 40 A (5 patients); Cp,p
lowered for molecules K 40 A and increased for molecules > 40 A
(16 patients). Indomethacin did not change C1 <40 A. In 18 out
of 21 patients with increased C1., > 40 A, a reduction was found
with indomethacin therapy. The effect was statistically significant.
In the untreated condition, SI was < 0.22 in 16, and > 0.22 in 17
patients. In both groups, SI was reduced after indomethacin ad-
ministration in 10 patients, and remained equal or increased in the
others. Of the 33 patients, 23 were on a sodium intake K 10
mmoles/day. In this group, SI went down in 16. In the nonsodium-
restricted group, SI went down in three patients. Statistically, the
conclusion that indomethacin would lower SI was not justified.
Neither the results with nor those with SI could be correlated
with underlying glomerular disease, endogenous creatinine clear-
ance, level of proteinuria, or degree of hypalbuminemia. There was
no correlation either with the effect of indomethacin on proteinuria
or, if present, on endogenous creatinine clearance. It can be con-
cluded that, if a nephrotic syndrome is associated with an increased
permeability for inert macromolecules with molecular radius > 40
A, indomethacin reduces this abnormal permeability. In contrast
to the findings of others, a similar effect on the clearance quotient
lgG/albumin was not found. Hulme and Pessina (1975) described
in normal rats an increased > 40 A under angiotensin in-
fusion. Donker et al (1975) reported that indomethacin suppresses
the volume regulatory increase of plasma renin activity in normal
man. It is tempting to speculate, against this background, that the
effect of indomethacin on glomerular permeability in the nephrotic
syndrome is not due to an influence on glomerular disease, but to
suppression of enhanced angiotensin activity.
The possible role of "fixed antigen" in the pathogenesis of immune
complex glomerulonephritis. B. Van Damme, G. J. Fleuren, W. W.
Bakker, R. L. Vernier, Ph. J. Hoedemaeker. Department of Pathol-
ogy, University of Groningen, Groningen. The Netherlands. The role
of circulating soluble immune complexes in the pathogenesis of
immune complex disease and especially in immune complex glomer-
ulonephritis is generally accepted. Experiments have shown that
immune complexes formed in antigen excess are soluble and may
be deposited in the glomerular basement membrane (GBM).
Through binding and activation of complement components, the
GBM may be damaged and inflammation will follow. To study
immune complex glomerulonephritis, a model for this disease was
developed in the rat through injection of rabbit antibodies directed
against brush border antigens from the tubules of the rat kidney.
This injection resulted in immediate localization of immune com-
plex aggregates in the GBM of both kidneys. It was shown, how-
ever, that in this model immune complexes were formed in anti-
body excess. Immune complexes formed in this way, however, were
not supposed to localize in the GBM, unless the antigen was
already present in the glomeruli. Immunohistology at the light
microscopic and the ultrastructural level showed that FxIA-like
antigens were present in the cell membranes of the glomerular
epithelial cells, along the foot processes and in the slit pore mem-
branes. Furthermore, it was shown that in absence of antigen, the
presence of rabbit and anti-rat FxIA antibodies resulted in the
localization of immune complex aggregates in the GBM. This was
demonstrated subsequently by "ex vivo" perfusion of the left kid-
ney of a rat with buffer, rabbit anti-Fx1A antibody, and again
buffer. Rat kidneys perfused with immune complexes and normal
rabbit lgG, and likewise having immunohistologic examinations of
the right nonperfused kidney, served as controls. From these re-
sults it was concluded that in this form of experimental glomerulo-
nephritis, a "fixed antigen" played an important role in the patho-
genesis. This new concept for the pathogenesis of immune complex
glomerulonephritis might also be relevant for other forms of
glomerulonephritis, including human membranous glomerul-
opathy.
Influence of sodium balance on the effects of angiotensin-Il block-
ade with saralasin. P. van Hoogdalem, A. J. M. Donker, and
F. H. H. Leenen. Department of Internal Medicine, Division of
Nephrology, State University of Graningen, and the Department of
Cardiology, Medical Faculty, University of Utrecht, the Nether-
lands. In patients with unilateral renovascular hypertension (N =
8), bilateral renovascular hypertension (N = 4), and essential
hypertension (N = 4), the effects of angiotensin-Il blockade with
sar'-ala'-angiotensin-I I (saralasin) on blood pressure, plasma re-
nm activity (PRA), glomerular filtration rate (GFR), and effective
renal plasma flow (ERPF) were studied, both on a normal sodium
intake (100 mEq/day) and after sodium depletion. On normal
sodium intake, saralasin induced a decrease in mean blood pres-
sure of —8 mm Hg in the unilateral renovascular group, —6 mm
Hg in the bilateral renovascular group, and an increase in mean
blood pressure of + 3 mm Hg in the essential hypertensive group.
Following sodium depletion, saralasin decreased mean blood pres-
sure by —33 mm Hg, —35mm Hg, and —18mm Hg, respectively.
The saralasin-induced decrease in blood pressure significantly cor-
related with the log of the initial PRA for all studies together and
for the different subgroups separately. PRA increased during the
blockade when blood pressure decreased. Saralasin infusion re-
sulted in decreases in ERPF in all three hypertension subgroups,
both on normal sodium intake and after sodium depletion. GFR
decreased, related to the hypotensive effect of saralasin. It is con-
cluded that the hypotensive action of saralasin closely correlates
with the level of circulating PRA, independent of the etiology of
the hypertension. The decrease in ERPF during infusion of sarala-
sin could be related to the agonistic activity of saralasin, the
hypotensive effect of saralasin, and/or the absence of a blocking
action of i.v. administered saralasin on stimulation of the renal
vascular receptors by endogenous angiotensin-Il formed intra-
renally.
